表型
遗传学
基因
生物
肥厚性心肌病
遗传异质性
心肌病
医学
内科学
心力衰竭
生物化学
作者
Cinzia Forleo,Anna Maria D’Erchia,Sandro Sorrentino,Caterina Manzari,Matteo Chiara,Massimo Iacoviello,Andrea Igoren Guaricci,Delia De Santis,Rita Leonarda Musci,Antonino La Spada,Vito Marangelli,Graziano Pesole,Stefano Favale
出处
期刊:PLOS ONE
[Public Library of Science]
日期:2017-07-27
卷期号:12 (7): e0181842-e0181842
被引量:50
标识
DOI:10.1371/journal.pone.0181842
摘要
Cardiomyopathies are a heterogeneous group of primary diseases of the myocardium, including hypertrophic cardiomyopathy (HCM), dilated cardiomyopathy (DCM), and arrhythmogenic right ventricular cardiomyopathy (ARVC), with higher morbidity and mortality. These diseases are genetically diverse and associated with rare mutations in a large number of genes, many of which overlap among the phenotypes. To better investigate the genetic overlap between these three phenotypes and to identify new genotype-phenotype correlations, we designed a custom gene panel consisting of 115 genes known to be associated with cardiomyopathic phenotypes and channelopathies. A cohort of 38 unrelated patients, 16 affected by DCM, 14 by HCM and 8 by ARVC, was recruited for the study on the basis of more severe phenotypes and family history of cardiomyopathy and/or sudden death. We detected a total of 142 rare variants in 40 genes, and all patients were found to be carriers of at least one rare variant. Twenty-eight of the 142 rare variants were also predicted as potentially pathogenic variants and found in 26 patients. In 23 out of 38 patients, we found at least one novel potential gene-phenotype association. In particular, we detected three variants in OBSCN gene in ARVC patients, four variants in ANK2 gene and two variants in DLG1, TRPM4, and AKAP9 genes in DCM patients, two variants in PSEN2 gene and four variants in AKAP9 gene in HCM patients. Overall, our results confirmed that cardiomyopathic patients could carry multiple rare gene variants; in addition, our investigation of the genetic overlap among cardiomyopathies revealed new gene-phenotype associations. Furthermore, as our study confirms, data obtained using targeted next-generation sequencing could provide a remarkable contribution to the molecular diagnosis of cardiomyopathies, early identification of patients at risk for arrhythmia development, and better clinical management of cardiomyopathic patients.
科研通智能强力驱动
Strongly Powered by AbleSci AI